Clinical Trials Logo
  1. Home
  2. Pseudarthrosis
  3. NCT03970941

Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis — EVIDENCE  

Pseudarthrosis Clinical Trial

Official title:
Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis

Clinical Trial Summary

Septic pseudarthrosis of long bones are complications that can unfortunately occur after the consolidation of a fracture and some situations present risks of superinfection, persistent infection or mechanical failure (30-40% risk of complications) that can lead to amputation. A possible saving situation used by CRIOAC ("Centre de Référence des Infections Ostéo-Articulaires Complexes") is the use of a bone substitute impregnated with an antibiotic allowing a high local concentration of this antibiotic. The aim of this study is to evaluate the cost of management of septic pseudarthrosis with two-stage treatment and CERAMENT® and the quality of life for this patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03970941
Study type Observational
Source Hospices Civils de Lyon
Contact Tristan FERRY, MD, PhD
Phone 0472071107
Email tristan.ferry@chu-lyon.fr
Status Recruiting
Phase
Start date September 5, 2019
Completion date September 2026
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01461005 - A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) N/A
Terminated NCT00424567 - Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures. Phase 1/Phase 2
Completed NCT04200872 - Observational Retrospective Study on the Clinical and Radiographic Outcomes of the Aseptic Pseudarthrosis Treatment of the Upper Limb
Completed NCT00916981 - Treatment of Atrophic Nonunion by Preosteoblast Cells Phase 1/Phase 2
Recruiting NCT05483387 - Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments. Phase 4
Recruiting NCT05583864 - Lumbar Fusion With Porous Versus Non-Porous Cages N/A
Completed NCT04418882 - Septic Management and Outcome of Open Fracture
Not yet recruiting NCT01756144 - rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport N/A
Enrolling by invitation NCT06103396 - Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs) Phase 1/Phase 2
Terminated NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Recruiting NCT06098157 - Tuebingen Register of Union Failure After Fractures of the Upper and Lower Extremities
Recruiting NCT02683252 - Musculoskeletal Non-tumoral Pathology Quantitative Perfusion N/A
Completed NCT00726128 - Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System